BIOTRIN INTERNATIONAL'S PARVOVIRUS B19 IGG IN VITRO DIAGNOSTIC DEVICE
FDA premarket approval P970054/S008 · decided 2010-03-19
Approval details
- PMA number
- P970054
- Supplement
- S008
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BIOTRIN INTERNATIONAL'S PARVOVIRUS B19 IGG IN VITRO DIAGNOSTIC DEVICE
- Generic name
- ASSAY,ENZYME LINKED IMMUNOSORBENT,PARVOVIRUS B19 IGG
- Applicant
- Diasorin
- Date received
- 2010-02-17
- Decision date
- 2010-03-19
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- MYL
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- Stillwater, MN
- Statement
- INTRODUCTION OF A NEW PRODUCTION PROCEDURE TO PREPARE A VIRAL MASTER STOCK, AND THE DOCUMENTATION OF THE TUBING PRIMING STEPS FOR THE PLATE COATING EQUIPMENT USED IN THE DEVICE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| LIAISON ALDOSTERONE, LIAISON ALDOSTERONE CONTROL SET, LIAISON ALDOSTERONE CALIBRATION VERIFIERS (K130321) | Diasorin | 2013-04-09 |